Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1950 1
1955 1
1956 2
1957 7
1958 5
1960 4
1961 6
1962 4
1963 7
1964 5
1965 5
1966 4
1967 7
1968 3
1969 1
1970 9
1971 5
1972 4
1973 8
1974 4
1976 6
1977 5
1978 9
1979 9
1980 7
1981 3
1982 5
1983 6
1984 5
1985 1
1986 6
1987 8
1988 5
1989 6
1990 7
1991 6
1992 8
1993 9
1994 5
1995 1
1996 10
1997 10
1998 10
1999 12
2000 10
2001 14
2002 17
2003 18
2004 7
2005 15
2006 11
2007 21
2008 24
2009 19
2010 25
2011 34
2012 29
2013 34
2014 35
2015 48
2016 35
2017 49
2018 52
2019 54
2020 54
2021 27
Text availability
Article attribute
Article type
Publication date

Search Results

818 results
Results by year
Filters applied: . Clear all
Page 1
Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events.
Bond TC, Szabo E, Gabriel S, Klastersky J, Tomey O, Mueller U, Schwartzberg L, Tang B. Bond TC, et al. Among authors: szabo e. J Oncol Pharm Pract. 2018 Sep;24(6):412-423. doi: 10.1177/1078155217714859. Epub 2017 Jun 14. J Oncol Pharm Pract. 2018. PMID: 28614980 Free PMC article. Review.
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study.
Thomas A, Vilimas R, Trindade C, Erwin-Cohen R, Roper N, Xi L, Krishnasamy V, Levy E, Mammen A, Nichols S, Chen Y, Velcheti V, Yin F, Szabo E, Pommier Y, Steinberg SM, Trepel JB, Raffeld M, Young HA, Khan J, Hewitt S, Lee JM. Thomas A, et al. Among authors: szabo e. J Thorac Oncol. 2019 Aug;14(8):1447-1457. doi: 10.1016/j.jtho.2019.04.026. Epub 2019 May 4. J Thorac Oncol. 2019. PMID: 31063862 Free PMC article. Clinical Trial.
Calreticulin inhibits commitment to adipocyte differentiation.
Szabo E, Qiu Y, Baksh S, Michalak M, Opas M. Szabo E, et al. J Cell Biol. 2015 Jan 19;208(2):249-50. doi: 10.1083/jcb.20071207812302014r. Epub 2015 Jan 12. J Cell Biol. 2015. PMID: 25583997 Free PMC article. No abstract available.
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.
Thomas A, Redon CE, Sciuto L, Padiernos E, Ji J, Lee MJ, Yuno A, Lee S, Zhang Y, Tran L, Yutzy W, Rajan A, Guha U, Chen H, Hassan R, Alewine CC, Szabo E, Bates SE, Kinders RJ, Steinberg SM, Doroshow JH, Aladjem MI, Trepel JB, Pommier Y. Thomas A, et al. Among authors: szabo e. J Clin Oncol. 2018 Jun 1;36(16):1594-1602. doi: 10.1200/JCO.2017.76.6915. Epub 2017 Dec 18. J Clin Oncol. 2018. PMID: 29252124 Free PMC article. Clinical Trial.
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Thomas A, Rajan A, Berman A, Tomita Y, Brzezniak C, Lee MJ, Lee S, Ling A, Spittler AJ, Carter CA, Guha U, Wang Y, Szabo E, Meltzer P, Steinberg SM, Trepel JB, Loehrer PJ, Giaccone G. Thomas A, et al. Among authors: szabo e. Lancet Oncol. 2015 Feb;16(2):177-86. doi: 10.1016/S1470-2045(14)71181-7. Epub 2015 Jan 13. Lancet Oncol. 2015. PMID: 25592632 Free PMC article. Clinical Trial.
TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages.
Li Y, James SJ, Wyllie DH, Wynne C, Czibula A, Bukhari A, Pye K, Bte Mustafah SM, Fajka-Boja R, Szabo E, Angyal A, Hegedus Z, Kovacs L, Hill AVS, Jefferies CA, Wilson HL, Yongliang Z, Kiss-Toth E. Li Y, et al. Among authors: szabo e. Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16479-16488. doi: 10.1073/pnas.1901090116. Epub 2019 Jul 25. Proc Natl Acad Sci U S A. 2019. PMID: 31346090 Free PMC article.
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.
Reyes-Uribe L, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, Vornik L, Liu DD, Revuelta M, Chang K, You YN, Kopelovich L, Wistuba II, Lee JJ, Sei S, Shoemaker RH, Szabo E, Richmond E, Umar A, Perloff M, Brown PH, Lipkin SM, Vilar E. Reyes-Uribe L, et al. Among authors: szabo e. Gut. 2021 Mar;70(3):555-566. doi: 10.1136/gutjnl-2020-320946. Epub 2020 Jul 8. Gut. 2021. PMID: 32641470 Free PMC article.
Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma.
Rajan A, Heery CR, Thomas A, Mammen AL, Perry S, O'Sullivan Coyne G, Guha U, Berman A, Szabo E, Madan RA, Ballester LY, Pittaluga S, Donahue RN, Tsai YT, Lepone LM, Chin K, Ginty F, Sood A, Hewitt SM, Schlom J, Hassan R, Gulley JL. Rajan A, et al. Among authors: szabo e. J Immunother Cancer. 2019 Oct 21;7(1):269. doi: 10.1186/s40425-019-0723-9. J Immunother Cancer. 2019. PMID: 31639039 Free PMC article.
Differences between tight and loose cultures: a 33-nation study.
Gelfand MJ, Raver JL, Nishii L, Leslie LM, Lun J, Lim BC, Duan L, Almaliach A, Ang S, Arnadottir J, Aycan Z, Boehnke K, Boski P, Cabecinhas R, Chan D, Chhokar J, D'Amato A, Ferrer M, Fischlmayr IC, Fischer R, Fülöp M, Georgas J, Kashima ES, Kashima Y, Kim K, Lempereur A, Marquez P, Othman R, Overlaet B, Panagiotopoulou P, Peltzer K, Perez-Florizno LR, Ponomarenko L, Realo A, Schei V, Schmitt M, Smith PB, Soomro N, Szabo E, Taveesin N, Toyama M, Van de Vliert E, Vohra N, Ward C, Yamaguchi S. Gelfand MJ, et al. Among authors: szabo e. Science. 2011 May 27;332(6033):1100-4. doi: 10.1126/science.1197754. Science. 2011. PMID: 21617077 Free article.
818 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page